A new ACC Scientific Statement focused on the management of atherosclerotic cardiovascular disease, aims to help clinicians overcome the perpetual challenge of balancing the risk of ischemia with the ...
As the new year begins, the landscape of cardiovascular medicine is undergoing a remarkable transformation, driven by groundbreaking technologies and innovative approaches that promise to ...
The Centers for Medicare and Medicaid Services (CMS) has issued the 2026 Hospital Outpatient Prospective Payment System (OPPS) and Ambulatory Surgical Center (ASC) Payment System final rule. CMS has ...
The U.S. Food and Drug Administration (FDA) has approved baxdrostat, a first-in-class oral aldosterone synthase inhibitor, as an add-on therapy for hypertension in adults whose blood pressure (BP) is ...
About 50% of U.S. adults will develop high BP during their lifetime. High BP is the most prevalent and modifiable risk factor for cardiovascular disease and all-cause mortality. The overarching BP ...
A new clinical guideline released by the ACC and the American Heart Association (AHA) includes new evidence and updated recommendations for managing patients with an ...
According to the ACC/American Heart Association (AHA) guideline, all adults should undergo cholesterol screening to help assess long-term cardiovascular risk. 5,6 Serum LDL-C levels <100 mg/dL are ...
The Centers for Medicare and Medicaid Services (CMS) has released the 2026 Medicare Physician Fee Schedule (PFS) final rule. The conversion factor for practitioners participating in a qualified ...
The newest clinical guideline released by the ACC and the American Heart Association (AHA) provides new and updated recommendations for preventing and optimally managing atrial fibrillation (AFib).
Psychological stress and mental health concerns are both risk factors for and possible complications of cardiovascular disease (CVD). These connections have been recognized in publications dating back ...
Global death counts due to cardiovascular disease (CVD) increased from 12.4 million in 1990 to 19.8 million in 2022, reflecting global population growth and aging and the contributions from ...
US and international guidelines advocate for the achievement of very low levels of LDL-C, particularly for individuals at highest risk. The concerns about stroke and cognitive issues with very low LDL ...